-
Loading metrics
Open Access
Peer-reviewed
Research Article
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study
-
Catherine A. Cosgrove ,
Contributed equally to this work with: Catherine A. Cosgrove, Charles J. Lacey
Affiliation Centre for Infection, St George’s, University of London, London, United Kingdom
⨯ -
Charles J. Lacey ,
Contributed equally to this work with: Catherine A. Cosgrove, Charles J. Lacey
Affiliation Hull York Medical School & Centre for Immunology and Infection, University of York, York, United Kingdom
⨯ -
Alethea V. Cope,
Affiliation Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom
⨯ -
Angela Bartolf,
Affiliation Centre for Infection, St George’s, University of London, London, United Kingdom
⨯ -
Georgina Morris,
Affiliation Hull York Medical School & Centre for Immunology and Infection, University of York, York, United Kingdom
⨯ -
Celine Yan,
Affiliation Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom
⨯ -
Susan Baden,
Affiliation Centre for Infection, St George’s, University of London, London, United Kingdom
⨯ -
Tom Cole,
Affiliation Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom
⨯ -
Darrick Carter,
Affiliation Infectious Disease Research Institute (IDRI), Seattle, WA, United States of America
⨯ -
Elizabeth Brodnicki,
Affiliation Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom
⨯ -
Xiaoying Shen,
Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America
⨯ -
Sarah Joseph,
Affiliation Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom
⨯ -
Stephen C. DeRosa,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Lili Peng,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Xuesong Yu,
Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Guido Ferrari,
Affiliations Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America, Department of Surgery, Duke University Medical Center, Durham, NC, United States of America
⨯ -
Mike Seaman,
Affiliation CAVD Neutralizing Antibody Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America
⨯ -
David C. Montefiori,
Affiliations Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America, Department of Surgery, Duke University Medical Center, Durham, NC, United States of America
⨯ -
Nicole Frahm,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯ -
Georgia D. Tomaras,
Affiliations Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America, Department of Surgery, Duke University Medical Center, Durham, NC, United States of America
⨯ -
Wolfgang Stöhr,
Affiliation Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom
⨯ -
Sheena McCormack,
Affiliation Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom
⨯ - [ ... ],
-
Robin J. Shattock
* E-mail: r.shattock@imperial.ac.uk
Affiliation Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom
⨯ - [ view all ]
- [ view less ]
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study
- Catherine A. Cosgrove,
- Charles J. Lacey,
- Alethea V. Cope,
- Angela Bartolf,
- Georgina Morris,
- Celine Yan,
- Susan Baden,
- Tom Cole,
- Darrick Carter,
- Elizabeth Brodnicki
- Published: May 9, 2016
- https://doi.org/10.1371/journal.pone.0152038